Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization
Pauline Thémans(University of Namur), Flora T. Musuamba(Inserm), Sophie Kiridis, F Wuillaume(Université Libre de Bruxelles), Jamila Hamdani, Kévin-Alexandre Delongie(Cliniques Universitaires Saint-Luc), Jean‐Michel Dogné(University of Namur), Rakan Nasreddine(Centre Hospitalier Universitaire de Saint-Pierre), Leïla Belkhir, Jean Cyr Yombi(Cliniques Universitaires Saint-Luc), Nicolás Dauby(Université Libre de Bruxelles), Xavier Wittebole(Cliniques Universitaires Saint-Luc), Veerle Verlinden, Cécile Lescrainier, Julien De Greef(Assistance Publique – Hôpitaux de Paris), Pierre Wallemacq(Cliniques Universitaires Saint-Luc), Martin Vandeputte(Université Libre de Bruxelles)
European Journal of Drug Metabolism and Pharmacokinetics
September 23, 2020
Cited by 12
Related Papers
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
|New England Journal of Medicine|2015|2.4k
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis
|JAMA|2013|797
A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens
|Virulence|2013|599
Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations Audit
|Open Forum Infectious Diseases|2018|530